To investigate the association between testosterone levels and the risk of dementia and to assess the effectiveness of testosterone supplement treatment in patients with cognitive impairment or dementia.
Methods:
We searched Pubmed, Cochrane Library, and EMBASE on September 30, 2019.
Results:
The risk factor portion of the review included 27 studies with 18 599 participants. Studies revealed inconsistent findings on the association between testosterone levels and the risk of all-cause dementia or Alzheimer disease (AD). The result from our meta-analysis showed an increased risk of all-cause dementia with decreasing total testosterone (total-T, 4572 participants, hazard ratio: 1.14, 95% CI: 1.04-1.26). Some studies also found an increased risk of AD with a lower level of total-T, free testosterone, and bioavailable testosterone. Testosterone supplement treatment may improve general cognitive function and motor response in the short term as measured by the Developmental Test of Visual-Motor Integration (mean difference [MD]: 4.4, 95% CI: 1.20-7.59) and the Mini-Mental State Examination (MD: 3.4, 95% CI: 0.83-5.97) and verbal memory as measured by story recall delay at 3 months (MD: 8.4, 95% CI: 0.49-16.3).
Conclusion:
Lower levels of testosterone may be associated with an increased risk of all-cause dementia or AD. Testosterone supplement treatment may or may not improve general cognitive function in patients with cognitive impairment/AD.
World Health Organization. The world health report: primary health care now more than ever. Published October 14, 2008. Accessed June 16, 2020. https://www.who.int/whr/2008/summary/en/
2.
LiHZhangXWangHYangBLiNJiZ. A Chinese cross-sectional study on symptoms in aging males: prevalence and associated factors. Am J Mens Health. 2019;13(2):1557988319838113. doi:10.1177/1557988319838113
3.
GliskyEL.Frontiers in Neuroscience Changes in Cognitive Function in Human Aging. In: RiddleDR, ed. Brain Aging: Models, Methods, and Mechanisms. CRC Press/Taylor & Francis Taylor & Francis Group, LLC; 2007.
4.
Martin PrinceAWAGuerchetM. World Alzheimer report 2015 the global impact of dementia an analysis of prevalence, incidence, cost and trends. World Alzheimer Report 2015; 2015.
OeppenJVaupelJW. Demography. Broken limits to life expectancy. Science. 2002;296(3):1029–1031.
7.
HarmanSMMetterEJTobinJD, Baltimore longitudinal study of aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J Clin Endocrinol Metab. 2001;86(2):724–731.
8.
MatsumotoAM. Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci. 2002;57(2):M76–M99.
9.
GiagulliVAGuastamacchiaEPergolaGD, et al.Testosterone deficiency in male: a risk factor for heart failure. Endocr Metab Immune Disord Drug Targets. 2013;13(1):92–99.
10.
HogervorstEMatthewsFEBrayneC. Are optimal levels of testosterone associated with better cognitive function in healthy older women and men?Biochim Biophys Acta. 2010;1800(10):1145–1152.
11.
ButchartJBirchBBassilyRLauraWCliveH. Male sex hormones and systemic inflammation in Alzheimer disease. Alzheimer Dis Assoc Disord. 2013;27(2):153–156.
12.
GreeneR. Sex steroids and brain functioning in the aging male. Aging Male. 2001;4(3):39–43.
13.
MohamadNVIma-NirwanaSChinKY. A review on the effects of testosterone supplementation in hypogonadal men with cognitive impairment. Curr Drug Targets. 2018;199(1):898–906.
14.
PonholzerAMadersbacherS. Re: Christina Wang, Eberhard Nieschlag, Ronald Swerdloff, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. Eur Urol. 2009;55(6):e92; author reply e93-94.
15.
HaydenJvan der WindtDCartwrightJPierreCClaireB. Assessing bias in studies of prognostic factors. Ann Int Med. 2013;158(4):280–286.
16.
HigginsJPTGS. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; 2011:Version 5.1.0.
17.
HigginsJPTGreenS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2011. Updated March 2011]. Accessed November 20, 2019. www.cochrane-handbook.org
18.
CarrJSBonhamLWMorgansAK, et al.Genetic variation in the androgen receptor and measures of plasma testosterone levels suggest androgen dysfunction in Alzheimer’s disease. Front Neurosci. 2018;12:529.
19.
MoffatSDZondermanABMetterEJ, et al.Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62:188–193.
20.
BurkhardtMSFosterJKClarnetteRM, et al.Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men. J Clin Endocrinol Metab. 2006;91(3):1168–1172.
21.
CarcaillonLBrailly-TabardSAncelinML, et al.Low testosterone and the risk of dementia in elderly men: Impact of age and education. Alzheimer’s Dementia. 2014;10(suppl 5): S306–S314.
22.
ChuLWTamSWongRLC, et al.Bioavailable testosterone predicts a lower risk of Alzheimer’s disease in older men. J Alzheimer’s Dis. 2010;21(4):1335–1345.
23.
CunninghamRLSinghMO’BryantSE, et al.Oxidative stress, testosterone, and cognition among caucasian and mexican-american men with and without alzheimer’s disease. J Alzheimer’s Dis. 2014;40(3):563–573.
24.
FondaSJBertrandRO’DonnellA, et al.Age, hormones, and cognitive functioning among middle-aged and elderly men: Cross-sectional evidence from the Massachusetts Male Aging Study. J Gerontol A Biol Sci Med Sci. 2005;60(3):385–390.
25.
FordAHYeapBBFlickerL, et al.Sex hormones and incident dementia in older men: The health in men study. Psychoneuroendocrinology. 2018;98:139–147.
26.
GeerlingsMIStrozykDMasakiK, et al.Endogenous sex hormones, cognitive decline, and future dementia in old men. Ann Neurol. 2006;60(3):346–355.
27.
HogervorstEBandelowSCombrinckMSmithAD. Low free testosterone is an independent risk factor for Alzheimer’s disease. Exp Gerontol. 2004;39(11-12):1633–1639.
28.
HogervorstECombrinckMSmithAD. Testosterone and gonadotropin levels in men with dementia. Neuroendocrinol Lett. 2003;24(3-4):203–208.
29.
HsuBCummingRGWaiteLM, et al.Longitudinal relationships between reproductive hormones and cognitive decline in older men: The concord health and ageing in men project. J Clin Endocrinol Metab. 2015;100(6):2223–2230.
30.
KarimiFHaghighiABPetramfarPAfreidoonA. Assessment of sex hormones and gonadotropin levels in Alzheimer patients. Galen Med J. 2015;4(4):139–145.
31.
LeblancESWangPYJanowskyJS, et al.Association between sex steroids and cognition in elderly men. Clin Endocrinol. 2010;72(3):393–403.
32.
LeeDMUlubaevATajarA, et al.Endogenous hormones, androgen receptor CAG repeat length and fluid cognition in middle-aged and older men: Results from the European Male Ageing Study. Eur J Endocrinol. 2010;162(6):1155–1164.
33.
LehmannDJHogervorstEWordenDR, et al.The androgen receptor CAG repeat and serum testosterone in the risk of Alzheimer’s disease in men. J Neurol Neurosur Psychiatry. 2004;75(1):163–164.
34.
Lessov-SchlaggarCNReedTSwanGE, et al.Association of sex steroid hormones with brain morphology and cognition in healthy elderly men. Neurology. 2005;65(10):1591–1596.
35.
MullerMAlemanAGrobbeeDE, et al.Endogenous sex hormone levels and cognitive function in aging men: is there an optimal level?Neurology. 2005;64(5):866–871.
36.
PennanenCLaaksoMPKivipeltoM, et al.Serum testosterone levels in males with Alzheimer’s disease. J Neuroendocrinol. 2004;16(2):95–98.
37.
SeidlJNMassmanPJ. Relationships between testosterone levels and cognition in patients with Alzheimer disease and nondemented elderly men. J Geriatr Psychiatry Neurol. 2015;28(1):27–39.
38.
SuravarapuSBergstralhEJFarmerSA, et al.Dementia and low testosterone and bioavailable testosterone levels in men: Possible increased risk. Alzheimer Dis Assoc Disord. 2006;20(3):138–140.
39.
TakayanagiYSpiraAPMcIntyreRSEatonWW. Sex hormone binding globulin and verbal memory in older men. Am J Geriatr Psychiatry. 2015;23(3):253–260.
40.
XingYQinWLiF, et al.Associations between sex hormones and cognitive and neuropsychiatric manifestations in vascular dementia (VaD). Arch Gerontol Geriatr. 2013;56(1):85–90.
41.
YaffeKLuiLYZmudaJCauleyJ. Sex hormones and cognitive function in older men. J Am Geriatr Soc. 2002;50(4):707–712.
42.
YaffeKBarnesDLindquistK, et al.Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol Aging. 2007;28(2):171–178.
43.
CherrierMMMatsumotoAMAmoryJK, et al.Testosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairment. Neurology. 2005;64(12):2063–2068.
44.
CherrierMMAndersonKShoferJ, et al.Testosterone treatment of men with mild cognitive impairment and low testosterone levels. Am J Alzheimers Dis Other Demen. 2015;30(4):421–430.
45.
KennyAMFabregasGSongC, et al.Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss. J Gerontol A Biol Sci Med Sci. 2004;59(1):75–78.
46.
TanRSPuSJ. A pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer’s disease. Aging Male. 2003;6(1):13–17.
47.
LuPHMastermanDAMulnardR, et al.Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol. 2006;63(2):177–185.
48.
PonholzerAMadersbacherSRauchenwaldM, et al.Serum androgen levels and their association to depression and Alzheimer dementia in a cohort of 75-year-old men over 5 years: Results of the VITA study. Int J Imp Res. 2009;21(3):187–191.
49.
Jimenez-RubioGHerrera-PerezJJHernandez-HernandezOTMartinez-MotaL. Relationship between androgen deficiency and memory impairment in aging and Alzheimer’s disease. Actas Esp Psiquiatr. 2017;45(5):227–247.
50.
GiagulliVAGuastamacchiaELicchelliBTriggianiV. Serum testosterone and cognitive function in ageing male: updating the evidence. Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):22–30.
51.
HollandJBandelowSHogervorstE. Testosterone levels and cognition in elderly men: A review. Maturitas. 2011;69(4):322–337.
52.
JungHJShinHS. Effect of testosterone replacement therapy on cognitive performance and depression in men with testosterone deficiency syndrome. World J Mens Health. 2016;34(3):194–199.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
